Issue 80, 2014

A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapy

Abstract

A novel cancer targeting and pH-responsive prodrug was successfully designed and synthesized. This M-prodrug was demonstrated to have real-time drug release monitoring capability based on the concept of contact-mediated quenching between doxorubicin and a coumarin derivative.

Graphical abstract: A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapy

Supplementary files

Article information

Article type
Communication
Submitted
01 Jul 2014
Accepted
13 Aug 2014
First published
13 Aug 2014

Chem. Commun., 2014,50, 11852-11855

A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapy

S. Li, L. Liu, H. Jia, W. Qiu, L. Rong, H. Cheng and X. Zhang, Chem. Commun., 2014, 50, 11852 DOI: 10.1039/C4CC05008H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements